- Investor's Business Daily•yesterday
Big U.S. pharmas AbbVie and Merck traded higher and flat, respectively, after reporting positive Q2 results, while France's Sanofi headed lower.
Looking at the earnings posted by Merck & Co. (MRK), I could not help but compare and contrast them with what Sanofi (SNY) said this morning. Like Sanofi had with Lantus, Merck has a mega-blockbuster with Januvia. Just as Lantus was getting long in the tooth and facing patent expiration
After hours: 41.95-0.68 (-1.59%) as of 5:16 PM EDT
|Bid||42.00 x 200|
|Ask||43.58 x 200|
|52wk Range||37.41 - 54.98|
|Day's Range||41.62 - 42.74|
|Avg Vol (3m)||2,273,442|
As of 4:02 PM EDT. Market closed.